# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Voltaire (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-EN002-SYN
- Date: 2026-04-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Honorine Delacroix-Mensah, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

One-week review of CT urography and kidney function; urology consultation and office cystoscopy today. **S**

## History of present illness

Voltaire returns one week after his first visit, with the catheter in place since then. The urine in the bag has gone from red to light pink, with one small clot four days ago and none since. He has had no fever, flank pain, or bladder spasm, and the catheter has drained without blockage. He stopped the diphenhydramine and the phosphate enemas; he slept poorly for two nights and now sleeps about five hours. His bowels open every one to two days on polyethylene glycol. He takes tamsulosin each evening without dizziness. He has cut his coffee to about five cups a day. The CT urography and chest CT were done two days after the first visit. He saw Dr. Bergström-Nwosu of urology this morning, who performed a flexible cystoscopy. **S**

| Element | Detail |
|---|---|
| Bleeding | Light pink urine; one small clot four days ago |
| Catheter | 16 Fr indwelling catheter draining well; no fever or spasm |
| Medicines | Diphenhydramine and phosphate enemas stopped; tamsulosin tolerated; polyethylene glycol continued |
| Imaging | CT urography and chest CT done two days after intake |
| Cystoscopy | Done by urology this morning |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever or sweats; appetite small but steady |
| Genitourinary | Positive | Light pink urine through the catheter; no flank pain, spasm, or leakage |
| Gastrointestinal | Negative | Bowels open every one to two days; no abdominal pain |
| Respiratory | Negative | No cough or blood in the sputum |
| Cardiovascular | Negative | No dizziness on standing |

5 systems reviewed. **S**

## Current medications

- Tamsulosin 0.4 mg oral capsule, one capsule at bedtime **S**
- Polyethylene glycol 3350, 17 g in a glass of water once daily **S**

## Allergies

- No known allergy **S**

## Objective

BP 132/70 mmHg; pulse 80 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 96% on room air; weight 54 kg; BMI 18.7 kg/m². All vital signs are synthetic.

Hemoglobin: 11.2 g/dL (low); Potassium: 4.6 mmol/L; BUN: 22 mg/dL; Creatinine: 1.24 mg/dL; eGFR: 58 mL/min/1.73 m² (low). All results are synthetic.

## Change since baseline

- Hemoglobin: 11.6 g/dL (low) at baseline, 11.2 g/dL (low) at this visit **S**
- Potassium: 5 mmol/L at baseline, 4.6 mmol/L at this visit **S**
- BUN: 34 mg/dL (high) at baseline, 22 mg/dL at this visit **S**
- Creatinine: 1.68 mg/dL (high) at baseline, 1.24 mg/dL at this visit **S**
- eGFR: 40 mL/min/1.73 m² (low) at baseline, 58 mL/min/1.73 m² (low) at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Thin, alert, and lively |
| Cardiovascular | Blood pressure 132/70 mmHg seated and 128/68 mmHg standing; heart rate 80, regular |
| Abdomen | Soft and non-tender; bladder not palpable |
| Genitourinary | Catheter draining light pink urine without clots; meatus clean |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Visible blood in the urine with difficult urination** (R31.0). CT urography shows a 4.2 cm sessile mass of the posterior bladder wall extending to the dome, with wall thickening and perivesical stranding, clear upper tracts, and no enlarged nodes; the chest CT is clear. Cystoscopy today found a solid, partly necrotic tumor with white keratinizing plaques. Urine culture showed no growth, and cytology showed atypical squamous cells suspicious for malignancy. A muscle-invasive bladder cancer is likely, possibly of squamous type; resection will give the diagnosis and depth. Hemoglobin 11.2 g/dL is stable. **S**
   - Transurethral resection of the bladder tumor with examination under anesthesia in two days, as Dr. Bergström-Nwosu advises.
   - Catheter stays in until after the resection.
   - Call for clots, a blocked catheter, or fever.
2. **Acute kidney injury from bladder outlet obstruction** (N17.9). Creatinine 1.24 mg/dL (eGFR 58), down from 1.68, BUN 22 mg/dL, and potassium 4.6 mmol/L after a week of drainage: resolved, close to his creatinine of 1.1 a year ago. **S**
   - Kidney function with each blood test during treatment.
3. **Benign prostatic hyperplasia with lower urinary tract symptoms** (N40.1). Prostate about 78 mL on CT with a median lobe; enlarged, firm, smooth gland on examination; PSA 6.4 ng/mL, a PSA density of 0.08, in keeping with the gland's size and the retention, catheter, and bleeding. By shared decision, no prostate MRI or biopsy: at 83, with a bladder tumor that will set his course, a prostate cancer found now would not change treatment. **S**
   - Continue tamsulosin.
   - Trial without catheter after the resection, when he is free of infection.
4. **Chronic urinary retention** (R33.8). Drained by catheter; the anticholinergic sleep aid has been stopped. **S**
   - Catheter care reviewed; leg bag by day and a night bag.
5. **Chronic constipation** (K59.09). Bowels regular on polyethylene glycol alone after stopping the phosphate enemas, which carry a risk of dangerous phosphate levels with reduced kidney function. **S**
   - Continue polyethylene glycol daily.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Upper-tract imaging: multiphasic CT urography, with chest CT | Once, in the initial evaluation of gross hematuria | Completed today | Done two days after intake and reviewed today: bladder mass with possible extravesical extension, clear upper tracts, no nodes; chest clear |
| Examination | Cystoscopy | Once, in the initial evaluation of gross hematuria | Completed today | Flexible cystoscopy by urology today: 4 cm solid sessile tumor of the posterior wall and dome |
| Laboratory | Urine culture and urine cytology | Once, in the initial evaluation of gross hematuria (cytology for gross hematuria by expert consensus) | Completed today | Results from the first visit reviewed today: culture no growth; cytology atypical squamous cells suspicious for malignancy |
| Laboratory | Kidney function and potassium after relief of obstruction | Within one to two weeks of catheter drainage | Completed today | Creatinine 1.24 mg/dL (eGFR 58), BUN 22 mg/dL, potassium 4.6 mmol/L; recovered |
| Laboratory | Hemoglobin during gross hematuria | At each visit while bleeding continues | Completed today | 11.2 g/dL, stable from 11.6 |
| Laboratory | PSA interpretation | Once, when it would change management | Completed today | 6.4 ng/mL with a prostate of about 78 mL (density 0.08); no MRI or biopsy by shared decision |
| Survey | IPSS | Baseline and at every follow-up visit (CMID BPH) | Not indicated | Not scored while the catheter drains the bladder; 22 at intake before the catheter; next after the trial without catheter |
| Examination | Post-void residual | At baseline when retention is suspected, after a trial without catheter, and when symptoms change | Not indicated | Catheter in place; 460 mL at intake; repeat after the trial without catheter |
| Examination | Digital rectal examination | Baseline, then as clinically indicated | Up to date | Done at intake: enlarged, firm, smooth, no discrete nodule |
| Medication safety | Alpha-blocker tolerability (orthostatic blood pressure, dizziness) | At 4 to 12 weeks after starting, and at each visit in a frail older adult | Completed today | No postural drop (132/70 to 128/68 mmHg); no dizziness |
| Medication safety | Medication review for drugs that worsen retention or kidney function | At intake and at each change | Completed today | Diphenhydramine and sodium phosphate enemas stopped; no NSAIDs; no other anticholinergics |
| Self-management | Catheter care | While a catheter is in place | Completed today | Leg and night bags, hand hygiene, bag below the bladder, fluids 1.5 to 2 liters a day |
| Referral | Urology consultation | For gross hematuria and for retention with kidney injury | Completed today | Seen today; resection booked in two days |

## Goal progress

- Find the cause of the bleeding within three weeks. In progress; target 2026-04-22. **S**
- Relieve the retention and recover kidney function. In progress; target 2026-04-22. **S**
- Treatment that controls bleeding and local symptoms while keeping him at home and writing. In progress; target 2026-05-27. **S**
- Pain at or below 3 of 10 without sedation, falls, or constipation. In progress; target 2026-05-27. **S**
- A written plan for future care, with a named health care agent. In progress; target 2026-04-28. **S**

## Guideline basis

- Microhematuria: AUA/SUFU Guideline (2020; amended 2025) (2025), American Urological Association and Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction
- Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO Guideline (2017; Amended 2020, 2024) (2024), American Urological Association
- NCCN Clinical Practice Guidelines in Oncology: Bladder Cancer, Version 3.2026 (including non-urothelial histologies) (2026), National Comprehensive Cancer Network
- EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer (2026), European Association of Urology
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023 (2023), American Urological Association
- Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America (2009), Infectious Diseases Society of America
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society
- Prostate Cancer: Screening (2018), U.S. Preventive Services Task Force
- CMID: Clinical Monitoring Intelligence Database, urologic cancer and benign prostatic hyperplasia monographs (2026), Aether Forge

## Follow-up

- Resection in two days; chronic-care review with the pathology in about ten days; sooner for clots, a blocked catheter, or fever. **S**
- Next scheduled visit 2026-04-22: review of resection pathology, diagnosis, geriatric assessment, trial without catheter, and shared decision on treatment. **S**
